These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7905273)

  • 1. Hyperlipidemia and Hypertension: Interactions in Cardiovascular--Renal Diseases. Proceedings of a meeting. Belgium, February 26-28, 1993.
    Am J Hypertens; 1993 Nov; 6(11 Pt 2):301S-82S. PubMed ID: 7905273
    [No Abstract]   [Full Text] [Related]  

  • 2. The flame that lights the fire: oxidative stress, inflammation, and renal damage in angiotensin II-induced hypertension.
    Schiffrin EL
    Hypertension; 2008 Aug; 52(2):205-6. PubMed ID: 18541731
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of cardiovascular injury in renal disease.
    Rabelink TJ; Stroes ES; Koomans HA
    Blood Purif; 1996; 14(1):67-74. PubMed ID: 8718568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proceedings of a symposium on the kidney and lipids. Grenoble, France, 16-17 April 1999].
    Nephrologie; 2000; 21(7):315-98. PubMed ID: 11216451
    [No Abstract]   [Full Text] [Related]  

  • 5. Arterial hypertension greatly contributes to the development and evolution of cardiovascular and renal diseases. Editorial.
    Ruilope LM
    J Hypertens Suppl; 2009 Jun; 27(3):S1. PubMed ID: 19506445
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin resistance and cardiovascular disease.
    Ginsberg HN
    J Clin Invest; 2000 Aug; 106(4):453-8. PubMed ID: 10953019
    [No Abstract]   [Full Text] [Related]  

  • 7. A fat chance of renal injury.
    Koeners MP; Joles JA
    Kidney Int; 2007 Aug; 72(3):232-4. PubMed ID: 17653229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephropathy subsequent to hyperlipidemia.
    Teuscher AU; Weidmann P; Lerch M; Laissue JA
    Clin Nephrol; 2000 Jul; 54(1):64-7. PubMed ID: 10939759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension and cardiovascular risk in chronic kidney disease patients.
    Luño J; Rodriguez-Iturbe B; Ayus JC
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S157-8. PubMed ID: 17130254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New strategies to prevent cardiovascular risk in chronic kidney disease. Proceedings of the Sixth International Conference on Hypertension and the Kidney. February 2008. Madrid, Spain.
    Kidney Int Suppl; 2008 Dec; (111):S1-99. PubMed ID: 19263604
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperlipidemia and renal disease: the use of animal models in understanding pathophysiology and approaches to treatment.
    Stevenson FT; Kaysen GA
    Wien Klin Wochenschr; 1999 Apr; 111(8):307-14. PubMed ID: 10378311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney disease, hospitalized hypertension, and cardiovascular events: cause or consequence?
    Chertow GM; Chang TI
    Circulation; 2010 May; 121(20):2160-1. PubMed ID: 20458007
    [No Abstract]   [Full Text] [Related]  

  • 13. The metabolic syndrome and chronic kidney disease.
    Peralta CA; Kurella M; Lo JC; Chertow GM
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):361-5. PubMed ID: 16775449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertension and renal disease].
    Kamper AL; Pedersen EB; Strandgaard S
    Ugeskr Laeger; 2009 Jun; 171(25):2109-13. PubMed ID: 19671393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What to treat? The structural basis for renal and vascular complications and hypertension, and the role of angiotensin converting enzyme inhibition. Symposium, 26th meeting of the European Association for the Study of Diabetes. Dublin, Ireland, 10 September 1991.
    J Hypertens Suppl; 1992 Apr; 10(1):S1-53. PubMed ID: 1619498
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of hypertension, hyperlipidemia and cyclosporine A therapy on long-term renal allograft survival.
    Maeda H; Sakamoto K; Kashiwabara H; Hachisu T; Yamada H; Matsushita K; Yamada K; Yokoyama T
    Transplant Proc; 1996 Jun; 28(3):1633-4. PubMed ID: 8658816
    [No Abstract]   [Full Text] [Related]  

  • 17. Relative contributions of different cardiovascular risk factors to significant arterial stiffness.
    Hae Guen Song ; Eung Ju Kim ; Hong Seog Seo ; Seong Hwan Kim ; Chang Gyu Park ; Seong Woo Han ; Ryu KH
    Int J Cardiol; 2010 Mar; 139(3):263-8. PubMed ID: 19041146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of elderly hypertension].
    Ito S
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():333-7. PubMed ID: 16981564
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperlipidemia and the progression of renal disease.
    Keane WF; Kasiske BL; O'Donnell MP
    Am J Clin Nutr; 1988 Jan; 47(1):157-60. PubMed ID: 3276133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases.
    Rossignol P; Kessler M; Zannad F
    Curr Opin Nephrol Hypertens; 2013 Jan; 22(1):59-64. PubMed ID: 23165110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.